Peptides and Heparin Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2017 to 2026

  • Published : Jan-2018
  • Tables : 173
  • Figures : 129
  • Category : Healthcare
  • No. of Pages : 170
  • Report Code : FACT378MR
  • Format : ppt

Peptides are amino acids’ short chains connected through peptide bonds. Peptides are molecules that are commonly known as proteins, whose functions are determined on the basis of the amino acid sequence and size. Heparin is known as disaccharide anticoagulant, commonly referred to as blood thinner, which prevents formation of blood clots. Mast cells and basophils in a body produce heparin, which is stored in mast cells and secreted wherever injuries occur.

global peptides and heparin market

Drug Developers Shifting Back to Peptides owing to Mounting Challenges regarding Small Molecules

While the pharmaceutical sector discerned small molecules as the medicinal agents, therapeutic peptides were considered to be niche products. However, with mounting challenges regarding small molecules, drug developers are shifting their concentration back to small amino acid chains. Although peptides have been deemed ineffective for developing drugs, modern peptide drug designs and formulations have been developed for circumventing their weaknesses. For example, original requirement for injecting peptides such as insulin is fading, with more patient-friendly administrations progressively being developed. In addition, the current society that critically judges undesirable effects and environmental impact of the candidate medicines is embracing the safety offered by peptides.

Heparin is being extensively employed as an antitumor and anti-inflammatory agent. The anti-inflammatory characteristic of heparin, which prevents metastatic spreading of tumor cells, is a new research finding among healthcare professionals. The metastatic spreading of tumor cells is restricted by heparin through neutralization of cationic mediators, inhibition of heparanase, and adhesion molecules. Recent discoveries have meant that heparin is capable of targeting L- and P-selectin & integrin activity, as well as preventing cancer progression.

A new report by Fact.MR projects the global market for peptide and heparin to reflect an impressive expansion during the forecast period, 2017 to 2026. Revenues from the market are estimated to exceed US$ 34,000 Mn by 2026-end.

Market Taxonomy

Region

Product Type

Route of Administration 

Indication

Distribution Channel

North America

Sodium Heparin

Intravenous

Diabetes

Hospital Pharmacies

Latin America

Ammonium Heparin

Oral Route

Cardiovascular

Retail Pharmacies

Europe

lithium Heparin

Others

Cancer

Online Pharmacies

Japan

Icatibant

 

Metabolic Disorder

 

APEJ

Bivalirudin

 

Central Nervous Systems

 

MEA

Liraglutide

 

Other Indications

 

 

Exenatide

 

 

 

 

Goserelin

 

 

 

 

Bortezomib

 

 

 

 

Other Product Types

 

 

 

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

APEJ to Remain Most Remunerative Market for Peptide and Heparin

There has been a growing demand for new oral anticoagulants having better efficacy and safety profiles in Asia-Pacific excluding Japan (APEJ). Side effects related to heparin products, including complications of bleeding and heparin-induced thrombocytopenia has resulted into robust adoption of oral anticoagulants in the region. In addition, rising incidence of cancer, metabolic disorders, and hepatitis, along with advancements in peptide synthesis technology and rapid demand for various peptide therapies in the region are expected to drive the growth in APEJ. APEJ will remain the most remunerative market for peptide and heparin.

Liraglutide and ammonium heparin are expected to remain fast-expanding products in the market. In addition, sales of exenatide, lithium heparin, and sodium heparin will register a similar CAGR through 2026.

Key Research Findings from Fact.MR’s Report on Peptide and Heparin Market

  • Oral route of administration will remain preferred for peptide and heparin
  • Cancer will continue to be the dominant indication segment in the market, in terms of revenues
  • Hospital pharmacies will remain the most lucrative distribution channel for peptide and heparin

Competition Tracking

The global market for peptide and heparin is high fragmented and competitive owing to the presence of a large number of international and regional vendors. These vendors are continuously focusing on the development of generic formulations related to blood coagulation and several other novel therapeutic areas. Companies having the capability of manufacturing drugs for effective treatment of coagulation disorders, along with high efficacy and safety profiles are likely to gain maximum market shares in the foreseeable future. Key market participants identified by the report include Baxter, Celsus, Biofer S.p.A,, Hemmo Pharma, AmbioPharm, Inc., Wockhardt Ltd., Sun Pharmaceutical Industries Ltd., Bachem, Abbott Laboratories, Pfizer Inc., Aspen, Leo Pharma, Teva, Takeda, Sanofi, Novo Nordisk, and Eli Lilly.

NoteThe insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

1. Global Economic Outlook

2. Global Peptide and Heparin Market - Executive Summary

3. Global Peptide and Heparin Market Overview
3.1. Introduction
       3.1.1. Global Peptide and Heparin Market Taxonomy
       3.1.2. Global Peptide and Heparin Market Definition
3.2. Global Peptide and Heparin Market Size (US$ Mn) and Forecast, 2012-2026
       3.2.1. Global Peptide and Heparin Market Y-o-Y Growth
3.3. Global Peptide and Heparin Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. PESTLE Analysis
3.7. Product Lifecycle
3.8. List of Distributors
3.9. Key Participants Market Presence (Intensity Map) By Region

4. Global Peptide and Heparin Market Analysis and Forecast 2012-2026 
4.1. Global Peptide and Heparin Market Size and Forecast By Product Type , 2012-2026
       4.1.1. Sodium Heparin Market Size and Forecast, 2012-2026
                4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                4.1.1.2. Market Share Comparison, By Region
                4.1.1.3. Y-o-Y growth Comparison, By Region
       4.1.2. Ammonium Heparin Market Size and Forecast, 2012-2026
                4.1.2.1. Revenue (US$ Mn) Comparison, By Region
                4.1.2.2. Market Share Comparison, By Region
                4.1.2.3. Y-o-Y growth Comparison, By Region
       4.1.3. lithium Heparin Market Size and Forecast, 2012-2026
                4.1.3.1. Revenue (US$ Mn) Comparison, By Region
                4.1.3.2. Market Share Comparison, By Region
                4.1.3.3. Y-o-Y growth Comparison, By Region
       4.1.4. Icatibant Market Size and Forecast, 2012-2026
                4.1.4.1. Revenue (US$ Mn) Comparison, By Region
                4.1.4.2. Market Share Comparison, By Region
                4.1.4.3. Y-o-Y growth Comparison, By Region
       4.1.5. Bivalirudin Market Size and Forecast, 2012-2026
                4.1.5.1. Revenue (US$ Mn) Comparison, By Region
                4.1.5.2. Market Share Comparison, By Region
                4.1.5.3. Y-o-Y growth Comparison, By Region
       4.1.6. Liraglutide Market Size and Forecast, 2012-2026
                4.1.6.1. Revenue (US$ Mn) Comparison, By Region
                4.1.6.2. Market Share Comparison, By Region
                4.1.6.3. Y-o-Y growth Comparison, By Region
       4.1.7. Exenatide Market Size and Forecast, 2012-2026
                4.1.7.1. Revenue (US$ Mn) Comparison, By Region
                4.1.7.2. Market Share Comparison, By Region
                4.1.7.3. Y-o-Y growth Comparison, By Region
       4.1.8. Goserelin Market Size and Forecast, 2012-2026
                4.1.8.1. Revenue (US$ Mn) Comparison, By Region
                4.1.8.2. Market Share Comparison, By Region
                4.1.8.3. Y-o-Y growth Comparison, By Region
       4.1.9. Bortezomib Market Size and Forecast, 2012-2026
                4.1.9.1. Revenue (US$ Mn) Comparison, By Region
                4.1.9.2. Market Share Comparison, By Region
                4.1.9.3. Y-o-Y growth Comparison, By Region
       4.1.10. Other Product Types Market Size and Forecast, 2012-2026
                4.1.10.1. Revenue (US$ Mn) Comparison, By Region
                4.1.10.2. Market Share Comparison, By Region
                4.1.10.3. Y-o-Y growth Comparison, By Region
4.2. Global Peptide and Heparin Market Size and Forecast By Route of Administration , 2012-2026
       4.2.1. Intravenous Market Size and Forecast, 2012-2026
                4.2.1.1. Revenue (US$ Mn) Comparison, By Region
                4.2.1.2. Market Share Comparison, By Region
                4.2.1.3. Y-o-Y growth Comparison, By Region
       4.2.2. Oral Route Market Size and Forecast, 2012-2026
                4.2.2.1. Revenue (US$ Mn) Comparison, By Region
                4.2.2.2. Market Share Comparison, By Region
                4.2.2.3. Y-o-Y growth Comparison, By Region
       4.2.3. Others Market Size and Forecast, 2012-2026
                4.2.3.1. Revenue (US$ Mn) Comparison, By Region
                4.2.3.2. Market Share Comparison, By Region
                4.2.3.3. Y-o-Y growth Comparison, By Region
4.3. Global Peptide and Heparin Market Size and Forecast By Indication, 2012-2026
       4.3.1. Diabetes Market Size and Forecast, 2012-2026
                4.3.1.1. Revenue (US$ Mn) Comparison, By Region
                4.3.1.2. Market Share Comparison, By Region
                4.3.1.3. Y-o-Y growth Comparison, By Region
       4.3.2. Cardiovascular Market Size and Forecast, 2012-2026
                4.3.2.1. Revenue (US$ Mn) Comparison, By Region
                4.3.2.2. Market Share Comparison, By Region
                4.3.2.3. Y-o-Y growth Comparison, By Region
       4.3.3. Cancer Market Size and Forecast, 2012-2026
                4.3.3.1. Revenue (US$ Mn) Comparison, By Region
                4.3.3.2. Market Share Comparison, By Region
                4.3.3.3. Y-o-Y growth Comparison, By Region
       4.3.4. Metabolic Disorder Market Size and Forecast, 2012-2026
                4.3.4.1. Revenue (US$ Mn) Comparison, By Region
                4.3.4.2. Market Share Comparison, By Region
                4.3.4.3. Y-o-Y growth Comparison, By Region
       4.3.5. Central Nervous Systems Market Size and Forecast, 2012-2026
                4.3.5.1. Revenue (US$ Mn) Comparison, By Region
                4.3.5.2. Market Share Comparison, By Region
                4.3.5.3. Y-o-Y growth Comparison, By Region
       4.3.6. Other Indications Market Size and Forecast, 2012-2026
                4.3.6.1. Revenue (US$ Mn) Comparison, By Region
                4.3.6.2. Market Share Comparison, By Region
                4.3.6.3. Y-o-Y growth Comparison, By Region
4.4. Global Peptide and Heparin Market Size and Forecast By Distribution Channel, 2012-2026
       4.4.1. Hospital Pharmacies Market Size and Forecast, 2012-2026
                4.4.1.1. Revenue (US$ Mn) Comparison, By Region
                4.4.1.2. Market Share Comparison, By Region
                4.4.1.3. Y-o-Y growth Comparison, By Region
       4.4.2. Retail Pharmacies Market Size and Forecast, 2012-2026
                4.4.2.1. Revenue (US$ Mn) Comparison, By Region
                4.4.2.2. Market Share Comparison, By Region
                4.4.2.3. Y-o-Y growth Comparison, By Region
       4.4.3. Market Size and Forecast, 2012-2026
                4.4.3.1. Revenue (US$ Mn) Comparison, By Region
                4.4.3.2. Market Share Comparison, By Region
                4.4.3.3. Y-o-Y growth Comparison, By Region

5. North America Peptide and Heparin Market Size and Forecast, 2012-2026
5.1. North America Outlook 
5.2. North America Parent Market Outlook 
5.3. North America Target Market Outlook 
5.4. Revenue (US$ Mn) Comparison, By Country 
       5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
       5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
5.5. Revenue (US$ Mn) Comparison, By Product Type 
5.6. Revenue (US$ Mn) Comparison, By Route of Administration 
5.7. Revenue (US$ Mn) Comparison, By Indication 
5.8. Revenue (US$ Mn) Comparison, By Distribution Channel

6. Latin America Peptide and Heparin Market Size and Forecast, 2012-2026
6.1. Latin America Outlook 
6.2. Latin America Parent Market Outlook 
6.3. Latin America Target Market Outlook 
6.4. Revenue (US$ Mn) Comparison, By Country 
       6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
       6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
       6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
6.5. Revenue (US$ Mn) Comparison, By Product Type 
6.6. Revenue (US$ Mn) Comparison, By Route of Administration 
6.7. Revenue (US$ Mn) Comparison, By Indication 
6.8. Revenue (US$ Mn) Comparison, By Distribution Channel

7. Europe Peptide and Heparin Market Size and Forecast, 2012-2026
7.1. Europe Outlook 
7.2. Europe Parent Market Outlook 
7.3. Europe Target Market Outlook 
7.4. Revenue (US$ Mn) Comparison, By Country 
       7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
       7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
       7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
       7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
       7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
       7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
7.5. Revenue (US$ Mn) Comparison, By Product Type 
7.6. Revenue (US$ Mn) Comparison, By Route of Administration 
7.7. Revenue (US$ Mn) Comparison, By Indication 
7.8. Revenue (US$ Mn) Comparison, By Distribution Channel

8. Japan Peptide and Heparin Market Size and Forecast, 2012-2026
8.1. Japan Outlook 
8.2. Japan Parent Market Outlook 
8.3. Japan Target Market Outlook 
8.4. Revenue (US$ Mn) Comparison, By Country 
       8.4.1. Japan Market Size and Forecast (US$ Mn), 2012-2026
8.5. Revenue (US$ Mn) Comparison, By Product Type 
8.6. Revenue (US$ Mn) Comparison, By Route of Administration 
8.7. Revenue (US$ Mn) Comparison, By Indication 
8.8. Revenue (US$ Mn) Comparison, By Distribution Channel

9. APEJ Peptide and Heparin Market Size and Forecast, 2012-2026
9.1. APEJ Outlook 
9.2. APEJ Parent Market Outlook 
9.3. APEJ Target Market Outlook 
9.4. Revenue (US$ Mn) Comparison, By Country 
       9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
       9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
       9.4.3. Indonesia Market Size and Forecast (US$ Mn), 2012-2026
       9.4.4. South Korea Market Size and Forecast (US$ Mn), 2012-2026
       9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
       9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
9.5. Revenue (US$ Mn) Comparison, By Product Type 
9.6. Revenue (US$ Mn) Comparison, By Route of Administration 
9.7. Revenue (US$ Mn) Comparison, By Indication 
9.8. Revenue (US$ Mn) Comparison, By Distribution Channel

10. MEA Peptide and Heparin Market Size and Forecast, 2012-2026
10.1. MEA Outlook 
10.2. MEA Parent Market Outlook 
10.3. MEA Target Market Outlook 
10.4. Revenue (US$ Mn) Comparison, By Country 
       10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
       10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
       10.4.3. Turkey Market Size and Forecast (US$ Mn), 2012-2026
       10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
10.5. Revenue (US$ Mn) Comparison, By Product Type 
10.6. Revenue (US$ Mn) Comparison, By Route of Administration 
10.7. Revenue (US$ Mn) Comparison, By Indication 
10.8. Revenue (US$ Mn) Comparison, By Distribution Channel

11. Global Peptide and Heparin Market Company Share, Competition Landscape and Company Profiles
11.1. Company Share Analysis
11.2. Competition Landscape
11.3. Company Profiles
       11.3.1. Eli Lilly
       11.3.2. Novo Nordisk
       11.3.3. Sanofi
       11.3.4. Takeda
       11.3.5. Teva
       11.3.6. Leo Pharma
       11.3.7. Aspen
       11.3.8. Pfizer Inc.
       11.3.9. Abbott Laboratories
       11.3.10. Bachem
       11.3.11. Sun Pharmaceutical Industries Ltd
       11.3.12. Wockhardt Ltd.
       11.3.13. AmbioPharm, Inc
       11.3.14. Hemmo Pharma
       11.3.15. Biofer S.p.A
       11.3.18. Other Key Players

12. Research Methodology

13. Disclaimer

TABLE 1 Global Peptide and Heparin Market Value (US$ Mn), 2012-2017
TABLE 2 Global Peptide and Heparin Market Value (US$ Mn), 2018-2026
TABLE 3 Global Peptide and Heparin Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4 Global Sodium Heparin Segment Value (US$ Mn), By Region 2012-2017
TABLE 5 Global Sodium Heparin Segment Value (US$ Mn), By Region 2018-2026
TABLE 6 Global Sodium Heparin Segment Market Share, By Region 2012-2017
TABLE 7 Global Sodium Heparin Segment Market Share, By Region 2018-2026
TABLE 8 Global Sodium Heparin Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global Ammonium Heparin Segment Value (US$ Mn), By Region 2012-2017
TABLE 10 Global Ammonium Heparin Segment Value (US$ Mn), By Region 2018-2026
TABLE 11 Global Ammonium Heparin Segment Market Share, By Region 2012-2017
TABLE 12 Global Ammonium Heparin Segment Market Share, By Region 2018-2026
TABLE 13 Global Ammonium Heparin Segment Y-o-Y, By Region 2017-2026
TABLE 14 Global lithium Heparin Segment Value (US$ Mn), By Region 2012-2017
TABLE 15 Global lithium Heparin Segment Value (US$ Mn), By Region 2018-2026
TABLE 16 Global lithium Heparin Segment Market Share, By Region 2012-2017
TABLE 17 Global lithium Heparin Segment Market Share, By Region 2018-2026
TABLE 18 Global lithium Heparin Segment Y-o-Y, By Region 2017-2026
TABLE 19 Global Icatibant Segment Value (US$ Mn), By Region 2012-2017
TABLE 20 Global Icatibant Segment Value (US$ Mn), By Region 2018-2026
TABLE 21 Global Icatibant Segment Market Share, By Region 2012-2017
TABLE 22 Global Icatibant Segment Market Share, By Region 2018-2026
TABLE 23 Global Icatibant Segment Y-o-Y, By Region 2017-2026
TABLE 24 Global Bivalirudin Segment Value (US$ Mn), By Region 2012-2017
TABLE 25 Global Bivalirudin Segment Value (US$ Mn), By Region 2018-2026
TABLE 26 Global Bivalirudin Segment Market Share, By Region 2012-2017
TABLE 27 Global Bivalirudin Segment Market Share, By Region 2018-2026
TABLE 28 Global Bivalirudin Segment Y-o-Y, By Region 2017-2026
TABLE 29 Global Liraglutide Segment Value (US$ Mn), By Region 2012-2017
TABLE 30 Global Liraglutide Segment Value (US$ Mn), By Region 2018-2026
TABLE 31 Global Liraglutide Segment Market Share, By Region 2012-2017
TABLE 32 Global Liraglutide Segment Market Share, By Region 2018-2026
TABLE 33 Global Liraglutide Segment Y-o-Y, By Region 2017-2026
TABLE 34 Global Exenatide Segment Value (US$ Mn), By Region 2012-2017
TABLE 35 Global Exenatide Segment Value (US$ Mn), By Region 2018-2026
TABLE 36 Global Exenatide Segment Market Share, By Region 2012-2017
TABLE 37 Global Exenatide Segment Market Share, By Region 2018-2026
TABLE 38 Global Exenatide Segment Y-o-Y, By Region 2017-2026
TABLE 39 Global Goserelin Segment Value (US$ Mn), By Region 2012-2017
TABLE 40 Global Goserelin Segment Value (US$ Mn), By Region 2018-2026
TABLE 41 Global Goserelin Segment Market Share, By Region 2012-2017
TABLE 42 Global Goserelin Segment Market Share, By Region 2018-2026
TABLE 43 Global Goserelin Segment Y-o-Y, By Region 2017-2026
TABLE 44 Global Bortezomib Segment Value (US$ Mn), By Region 2012-2017
TABLE 45 Global Bortezomib Segment Value (US$ Mn), By Region 2018-2026
TABLE 46 Global Bortezomib Segment Market Share, By Region 2012-2017
TABLE 47 Global Bortezomib Segment Market Share, By Region 2018-2026
TABLE 48 Global Bortezomib Segment Y-o-Y, By Region 2017-2026
TABLE 49 Global Other Product Types Segment Value (US$ Mn), By Region 2012-2017
TABLE 50 Global Other Product Types Segment Value (US$ Mn), By Region 2018-2026
TABLE 51 Global Other Product Types Segment Market Share, By Region 2012-2017
TABLE 52 Global Other Product Types Segment Market Share, By Region 2018-2026
TABLE 53 Global Other Product Types Segment Y-o-Y, By Region 2017-2026
TABLE 54 Global Intravenous Segment Value (US$ Mn), By Region 2012-2017
TABLE 55 Global Intravenous Segment Value (US$ Mn), By Region 2018-2026
TABLE 56 Global Intravenous Segment Market Share, By Region 2012-2017
TABLE 57 Global Intravenous Segment Market Share, By Region 2018-2026
TABLE 58 Global Intravenous Segment Y-o-Y, By Region 2017-2026
TABLE 59 Global Oral Route Segment Value (US$ Mn), By Region 2012-2017
TABLE 60 Global Oral Route Segment Value (US$ Mn), By Region 2018-2026
TABLE 61 Global Oral Route Segment Market Share, By Region 2012-2017
TABLE 62 Global Oral Route Segment Market Share, By Region 2018-2026
TABLE 63 Global Oral Route Segment Y-o-Y, By Region 2017-2026
TABLE 64 Global Others Segment Value (US$ Mn), By Region 2012-2017
TABLE 65 Global Others Segment Value (US$ Mn), By Region 2018-2026
TABLE 66 Global Others Segment Market Share, By Region 2012-2017
TABLE 67 Global Others Segment Market Share, By Region 2018-2026
TABLE 68 Global Others Segment Y-o-Y, By Region 2017-2026
TABLE 69 Global Diabetes Segment Value (US$ Mn), By Region 2012-2017
TABLE 70 Global Diabetes Segment Value (US$ Mn), By Region 2018-2026
TABLE 71 Global Diabetes Segment Market Share, By Region 2012-2017
TABLE 72 Global Diabetes Segment Market Share, By Region 2018-2026
TABLE 73 Global Diabetes Segment Y-o-Y, By Region 2017-2026
TABLE 74 Global Cardiovascular Segment Value (US$ Mn), By Region 2012-2017
TABLE 75 Global Cardiovascular Segment Value (US$ Mn), By Region 2018-2026
TABLE 76 Global Cardiovascular Segment Market Share, By Region 2012-2017
TABLE 77 Global Cardiovascular Segment Market Share, By Region 2018-2026
TABLE 78 Global Cardiovascular Segment Y-o-Y, By Region 2017-2026
TABLE 79 Global Cancer Segment Value (US$ Mn), By Region 2012-2017
TABLE 80 Global Cancer Segment Value (US$ Mn), By Region 2018-2026
TABLE 81 Global Cancer Segment Market Share, By Region 2012-2017
TABLE 82 Global Cancer Segment Market Share, By Region 2018-2026
TABLE 83 Global Cancer Segment Y-o-Y, By Region 2017-2026
TABLE 84 Global Metabolic Disorder Segment Value (US$ Mn), By Region 2012-2017
TABLE 85 Global Metabolic Disorder Segment Value (US$ Mn), By Region 2018-2026
TABLE 86 Global Metabolic Disorder Segment Market Share, By Region 2012-2017
TABLE 87 Global Metabolic Disorder Segment Market Share, By Region 2018-2026
TABLE 88 Global Metabolic Disorder Segment Y-o-Y, By Region 2017-2026
TABLE 89 Global Central Nervous Systems Segment Value (US$ Mn), By Region 2012-2017
TABLE 90 Global Central Nervous Systems Segment Value (US$ Mn), By Region 2018-2026
TABLE 91 Global Central Nervous Systems Segment Market Share, By Region 2012-2017
TABLE 92 Global Central Nervous Systems Segment Market Share, By Region 2018-2026
TABLE 93 Global Central Nervous Systems Segment Y-o-Y, By Region 2017-2026
TABLE 94 Global Other Indications Segment Value (US$ Mn), By Region 2012-2017
TABLE 95 Global Other Indications Segment Value (US$ Mn), By Region 2018-2026
TABLE 96 Global Other Indications Segment Market Share, By Region 2012-2017
TABLE 97 Global Other Indications Segment Market Share, By Region 2018-2026
TABLE 98 Global Other Indications Segment Y-o-Y, By Region 2017-2026
TABLE 99 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 100 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 101 Global Hospital Pharmacies Segment Market Share, By Region 2012-2017
TABLE 102 Global Hospital Pharmacies Segment Market Share, By Region 2018-2026
TABLE 103 Global Hospital Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 104 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 105 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 106 Global Retail Pharmacies Segment Market Share, By Region 2012-2017
TABLE 107 Global Retail Pharmacies Segment Market Share, By Region 2018-2026
TABLE 108 Global Retail Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 109 Global Online Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 110 Global Online Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 111 Global Online Pharmacies Segment Market Share, By Region 2012-2017
TABLE 112 Global Online Pharmacies Segment Market Share, By Region 2018-2026
TABLE 113 Global Online Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 114 North America Peptide and Heparin Market Value (US$ Mn), By Country 2012-2017
TABLE 115 North America Peptide and Heparin Market Value (US$ Mn), By Country 2018-2026
TABLE 116 North America Peptide and Heparin Market Value (US$ Mn), By Product Type 2012-2017
TABLE 117 North America Peptide and Heparin Market Value (US$ Mn), By Product Type 2018-2026
TABLE 118 North America Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2012-2017
TABLE 119 North America Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2018-2026
TABLE 120 North America Peptide and Heparin Market Value (US$ Mn), By Indication 2012-2017
TABLE 121 North America Peptide and Heparin Market Value (US$ Mn), By Indication 2018-2026
TABLE 122 North America Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2012-2017
TABLE 123 North America Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2018-2026
TABLE 124 Latin America Peptide and Heparin Market Value (US$ Mn), By Country 2012-2017
TABLE 125 Latin America Peptide and Heparin Market Value (US$ Mn), By Country 2018-2026
TABLE 126 Latin America Peptide and Heparin Market Value (US$ Mn), By Product Type 2012-2017
TABLE 127 Latin America Peptide and Heparin Market Value (US$ Mn), By Product Type 2018-2026
TABLE 128 Latin America Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2012-2017
TABLE 129 Latin America Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2018-2026
TABLE 130 Latin America Peptide and Heparin Market Value (US$ Mn), By Indication 2012-2017
TABLE 131 Latin America Peptide and Heparin Market Value (US$ Mn), By Indication 2018-2026
TABLE 132 Latin America Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2012-2017
TABLE 133 Latin America Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2018-2026
TABLE 134 Europe Peptide and Heparin Market Value (US$ Mn), By Country 2012-2017
TABLE 135 Europe Peptide and Heparin Market Value (US$ Mn), By Country 2018-2026
TABLE 136 Europe Peptide and Heparin Market Value (US$ Mn), By Product Type 2012-2017
TABLE 137 Europe Peptide and Heparin Market Value (US$ Mn), By Product Type 2018-2026
TABLE 138 Europe Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2012-2017
TABLE 139 Europe Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2018-2026
TABLE 140 Europe Peptide and Heparin Market Value (US$ Mn), By Indication 2012-2017
TABLE 141 Europe Peptide and Heparin Market Value (US$ Mn), By Indication 2018-2026
TABLE 142 Europe Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2012-2017
TABLE 143 Europe Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2018-2026
TABLE 144 Japan Peptide and Heparin Market Value (US$ Mn), By Country 2012-2017
TABLE 145 Japan Peptide and Heparin Market Value (US$ Mn), By Country 2018-2026
TABLE 146 Japan Peptide and Heparin Market Value (US$ Mn), By Product Type 2012-2017
TABLE 147 Japan Peptide and Heparin Market Value (US$ Mn), By Product Type 2018-2026
TABLE 148 Japan Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2012-2017
TABLE 149 Japan Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2018-2026
TABLE 150 Japan Peptide and Heparin Market Value (US$ Mn), By Indication 2012-2017
TABLE 151 Japan Peptide and Heparin Market Value (US$ Mn), By Indication 2018-2026
TABLE 152 Japan Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2012-2017
TABLE 153 Japan Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2018-2026
TABLE 154 APEJ Peptide and Heparin Market Value (US$ Mn), By Country 2012-2017
TABLE 155 APEJ Peptide and Heparin Market Value (US$ Mn), By Country 2018-2026
TABLE 156 APEJ Peptide and Heparin Market Value (US$ Mn), By Product Type 2012-2017
TABLE 157 APEJ Peptide and Heparin Market Value (US$ Mn), By Product Type 2018-2026
TABLE 158 APEJ Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2012-2017
TABLE 159 APEJ Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2018-2026
TABLE 160 APEJ Peptide and Heparin Market Value (US$ Mn), By Indication 2012-2017
TABLE 161 APEJ Peptide and Heparin Market Value (US$ Mn), By Indication 2018-2026
TABLE 162 APEJ Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2012-2017
TABLE 163 APEJ Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2018-2026
TABLE 164 MEA Peptide and Heparin Market Value (US$ Mn), By Country 2012-2017
TABLE 165 MEA Peptide and Heparin Market Value (US$ Mn), By Country 2018-2026
TABLE 166 MEA Peptide and Heparin Market Value (US$ Mn), By Product Type 2012-2017
TABLE 167 MEA Peptide and Heparin Market Value (US$ Mn), By Product Type 2018-2026
TABLE 168 MEA Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2012-2017
TABLE 169 MEA Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2018-2026
TABLE 170 MEA Peptide and Heparin Market Value (US$ Mn), By Indication 2012-2017
TABLE 171 MEA Peptide and Heparin Market Value (US$ Mn), By Indication 2018-2026
TABLE 172 MEA Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2012-2017
TABLE 173 MEA Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2018-2026

FIG. 1 Global Peptide and Heparin Market Value (US$ Mn), 2012-2017
FIG. 2 Global Peptide and Heparin Market Value (US$ Mn) Forecast, 2018-2026
FIG. 3 Global Peptide and Heparin Market Value (US$ Mn) and Y-o-Y, 2017-2026
FIG. 4 Global Sodium Heparin Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 5 Global Sodium Heparin Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 6 Global Sodium Heparin Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 7 Global Ammonium Heparin Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 8 Global Ammonium Heparin Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 9 Global Ammonium Heparin Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 10 Global lithium Heparin Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 11 Global lithium Heparin Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 12 Global lithium Heparin Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 13 Global Icatibant Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 14 Global Icatibant Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 15 Global Icatibant Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 16 Global Bivalirudin Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 17 Global Bivalirudin Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 18 Global Bivalirudin Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 19 Global Liraglutide Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 20 Global Liraglutide Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 21 Global Liraglutide Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 22 Global Exenatide Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 23 Global Exenatide Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 24 Global Exenatide Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 25 Global Goserelin Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 26 Global Goserelin Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 27 Global Goserelin Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 28 Global Bortezomib Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 29 Global Bortezomib Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 30 Global Bortezomib Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 31 Global Other Product Types Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 32 Global Other Product Types Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 33 Global Other Product Types Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 34 Global Intravenous Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 35 Global Intravenous Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 36 Global Intravenous Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 37 Global Oral Route Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 38 Global Oral Route Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 39 Global Oral Route Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 40 Global Others Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 41 Global Others Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 42 Global Others Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 43 Global Diabetes Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 44 Global Diabetes Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 45 Global Diabetes Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 46 Global Cardiovascular Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 47 Global Cardiovascular Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 48 Global Cardiovascular Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 49 Global Cancer Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 50 Global Cancer Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 51 Global Cancer Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 52 Global Metabolic Disorder Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 53 Global Metabolic Disorder Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 54 Global Metabolic Disorder Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 55 Global Central Nervous Systems Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 56 Global Central Nervous Systems Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 57 Global Central Nervous Systems Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 58 Global Other Indications Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 59 Global Other Indications Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 60 Global Other Indications Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 61 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 62 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 63 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 64 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 65 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 66 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 67 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 68 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 69 Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 70 North America Peptide and Heparin Market Value (US$ Mn), By Country 2012-2017
FIG. 71 North America Peptide and Heparin Market Value (US$ Mn), By Country 2018-2026
FIG. 72 North America Peptide and Heparin Market Value (US$ Mn), By Product Type 2012-2017
FIG. 73 North America Peptide and Heparin Market Value (US$ Mn), By Product Type 2018-2026
FIG. 74 North America Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2012-2017
FIG. 75 North America Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2018-2026
FIG. 76 North America Peptide and Heparin Market Value (US$ Mn), By Indication 2012-2017
FIG. 77 North America Peptide and Heparin Market Value (US$ Mn), By Indication 2018-2026
FIG. 78 North America Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2012-2017
FIG. 79 North America Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2018-2026
FIG. 80 Latin America Peptide and Heparin Market Value (US$ Mn), By Country 2012-2017
FIG. 81 Latin America Peptide and Heparin Market Value (US$ Mn), By Country 2018-2026
FIG. 82 Latin America Peptide and Heparin Market Value (US$ Mn), By Product Type 2012-2017
FIG. 83 Latin America Peptide and Heparin Market Value (US$ Mn), By Product Type 2018-2026
FIG. 84 Latin America Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2012-2017
FIG. 85 Latin America Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2018-2026
FIG. 86 Latin America Peptide and Heparin Market Value (US$ Mn), By Indication 2012-2017
FIG. 87 Latin America Peptide and Heparin Market Value (US$ Mn), By Indication 2018-2026
FIG. 88 Latin America Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2012-2017
FIG. 89 Latin America Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2018-2026
FIG. 90 Europe Peptide and Heparin Market Value (US$ Mn), By Country 2012-2017
FIG. 91 Europe Peptide and Heparin Market Value (US$ Mn), By Country 2018-2026
FIG. 92 Europe Peptide and Heparin Market Value (US$ Mn), By Product Type 2012-2017
FIG. 93 Europe Peptide and Heparin Market Value (US$ Mn), By Product Type 2018-2026
FIG. 94 Europe Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2012-2017
FIG. 95 Europe Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2018-2026
FIG. 96 Europe Peptide and Heparin Market Value (US$ Mn), By Indication 2012-2017
FIG. 97 Europe Peptide and Heparin Market Value (US$ Mn), By Indication 2018-2026
FIG. 98 Europe Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2012-2017
FIG. 99 Europe Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2018-2026
FIG. 100 Japan Peptide and Heparin Market Value (US$ Mn), By Country 2012-2017
FIG. 101 Japan Peptide and Heparin Market Value (US$ Mn), By Country 2018-2026
FIG. 102 Japan Peptide and Heparin Market Value (US$ Mn), By Product Type 2012-2017
FIG. 103 Japan Peptide and Heparin Market Value (US$ Mn), By Product Type 2018-2026
FIG. 104 Japan Peptide and Heparin Market Value (US$ Mn), By Indication 2012-2017
FIG. 105 Japan Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2018-2026
FIG. 106 Japan Peptide and Heparin Market Value (US$ Mn), By Indication 2012-2017
FIG. 107 Japan Peptide and Heparin Market Value (US$ Mn), By Indication 2018-2026
FIG. 108 Japan Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2012-2017
FIG. 109 Japan Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2018-2026
FIG. 110 APEJ Peptide and Heparin Market Value (US$ Mn), By Country 2012-2017
FIG. 111 APEJ Peptide and Heparin Market Value (US$ Mn), By Country 2018-2026
FIG. 112 APEJ Peptide and Heparin Market Value (US$ Mn), By Product Type 2012-2017
FIG. 113 APEJ Peptide and Heparin Market Value (US$ Mn), By Product Type 2018-2026
FIG. 114 APEJ Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2012-2017
FIG. 115 APEJ Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2018-2026
FIG. 116 APEJ Peptide and Heparin Market Value (US$ Mn), By Indication 2012-2017
FIG. 117 APEJ Peptide and Heparin Market Value (US$ Mn), By Indication 2018-2026
FIG. 118 APEJ Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2012-2017
FIG. 119 APEJ Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2018-2026
FIG. 120 MEA Peptide and Heparin Market Value (US$ Mn), By Country 2012-2017
FIG. 121 MEA Peptide and Heparin Market Value (US$ Mn), By Country 2018-2026
FIG. 122 MEA Peptide and Heparin Market Value (US$ Mn), By Product Type 2012-2017
FIG. 123 MEA Peptide and Heparin Market Value (US$ Mn), By Product Type 2018-2026
FIG. 124 MEA Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2012-2017
FIG. 125 MEA Peptide and Heparin Market Value (US$ Mn), By Route of Administration 2018-2026
FIG. 126 MEA Peptide and Heparin Market Value (US$ Mn), By Indication 2012-2017
FIG. 127 MEA Peptide and Heparin Market Value (US$ Mn), By Indication 2018-2026
FIG. 128 MEA Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2012-2017
FIG. 129 MEA Peptide and Heparin Market Value (US$ Mn), By Distribution Channel2018-2026

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benefits of Becoming a Fact.MR Client

  • Access to our global market coverage
  • Periodic updates on your sector
  • Exclusive discounts and offers
  • Greater flexibility for customization
  • Quick-research assistance for ad-hoc needs
  • Access to credible insights Fact.MR analyst interactions
  • Access to Fact.MR tools and research to fuel strategy development